InBioGen Co Ltd (101140) - Cash Flow Conversion Efficiency
Based on the latest financial reports, InBioGen Co Ltd (101140) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.67 Billion ≈ $-1.13 Million USD) by net assets (₩170.78 Billion ≈ $115.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see InBioGen Co Ltd (101140) market capitalisation for the company's overall valuation and market capitalisation.
InBioGen Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how InBioGen Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
InBioGen Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of InBioGen Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of InBioGen Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT Sarimelati Kencana Tbk
JK:PZZA
|
0.076x |
|
Rossmax International Ltd
TWO:4121
|
0.044x |
|
Workhorse Group Inc
NASDAQ:WKHS
|
-3.354x |
|
Marti Otel Isletmeleri AS
IS:MARTI
|
-0.004x |
|
Destini Bhd
KLSE:7212
|
-0.126x |
|
Axita Cotton Limited
NSE:AXITA
|
0.010x |
|
Vate Technology Co Ltd
TWO:5344
|
-0.022x |
|
Success Prime Corp
TW:2496
|
0.177x |
Annual Cash Flow Conversion Efficiency for InBioGen Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of InBioGen Co Ltd from 2013 to 2024. View InBioGen Co Ltd (101140) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩159.84 Billion ≈ $108.32 Million |
₩-33.13 Million ≈ $-22.45K |
0.000x | +97.07% |
| 2023-12-31 | ₩148.68 Billion ≈ $100.76 Million |
₩-1.05 Billion ≈ $-712.04K |
-0.007x | +93.59% |
| 2022-12-31 | ₩104.42 Billion ≈ $70.76 Million |
₩-11.51 Billion ≈ $-7.80 Million |
-0.110x | -177.48% |
| 2021-12-31 | ₩178.02 Billion ≈ $120.64 Million |
₩-7.07 Billion ≈ $-4.79 Million |
-0.040x | +61.49% |
| 2020-12-31 | ₩77.91 Billion ≈ $52.80 Million |
₩-8.03 Billion ≈ $-5.44 Million |
-0.103x | -77.77% |
| 2019-12-31 | ₩66.00 Billion ≈ $44.72 Million |
₩-3.83 Billion ≈ $-2.59 Million |
-0.058x | +20.27% |
| 2018-12-31 | ₩23.35 Billion ≈ $15.83 Million |
₩-1.70 Billion ≈ $-1.15 Million |
-0.073x | -93.19% |
| 2017-12-31 | ₩11.32 Billion ≈ $7.67 Million |
₩-426.44 Million ≈ $-288.99K |
-0.038x | -162.82% |
| 2016-12-31 | ₩5.75 Billion ≈ $3.90 Million |
₩344.75 Million ≈ $233.63K |
0.060x | +104.27% |
| 2015-12-31 | ₩7.80 Billion ≈ $5.29 Million |
₩-10.96 Billion ≈ $-7.43 Million |
-1.405x | -732.60% |
| 2014-12-31 | ₩4.12 Billion ≈ $2.79 Million |
₩-695.95 Million ≈ $-471.63K |
-0.169x | +45.32% |
| 2013-12-31 | ₩3.67 Billion ≈ $2.49 Million |
₩-1.13 Billion ≈ $-767.47K |
-0.309x | -- |
About InBioGen Co Ltd
INBIOGEN Co., Ltd. engages in the manufacture and distribution of footwear products in South Korea. It is also involved in distribution of wood pellets; kiosk; and food and beverage businesses. The company was formerly known as BTONE CO.,Ltd. INBIOGEN Co., Ltd. was founded in 1949 and is headquartered in Seoul, South Korea.